Next‐generation bromodomain inhibitors of the SWI/SNF complex enhance DNA damage and cell death in glioblastoma

Glioblastoma (GBM) is an aggressive brain cancer with a poor prognosis. While surgical resection is the primary treatment, adjuvant temozolomide (TMZ) chemotherapy and radiotherapy only provide slight improvement in disease course and outcome. Unfortunately, most treated patients experience recurren...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Chuanhe, He, Yali, Wang, Yinan, McKinnon, Peter J., Shahani, Vijay, Miller, Duane D., Pfeffer, Lawrence M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494295/
https://www.ncbi.nlm.nih.gov/pubmed/37593885
http://dx.doi.org/10.1111/jcmm.17907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494295/
https://www.ncbi.nlm.nih.gov/pubmed/37593885
http://dx.doi.org/10.1111/jcmm.17907

Ejemplares similares